pamidronate has been researched along with Thalassemia in 2 studies
Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteoporosis is a common complication in thalassemia major (TM)." | 1.35 | Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits. ( Cheng, FW; Chu, Y; Lee, V; Leung, TF; Leung, WK; Li, CK; Shing, MM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, TF | 1 |
| Chu, Y | 1 |
| Lee, V | 1 |
| Cheng, FW | 1 |
| Leung, WK | 1 |
| Shing, MM | 1 |
| Li, CK | 1 |
| Chatterjee, R | 1 |
| Bajoria, R | 1 |
1 trial available for pamidronate and Thalassemia
| Article | Year |
|---|---|
Osteopenia-osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment.
Topics: Absorptiometry, Photon; Anti-Inflammatory Agents; Bone Diseases, Metabolic; Diphosphonates; Female; | 2009 |
1 other study available for pamidronate and Thalassemia
| Article | Year |
|---|---|
Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.
Topics: Adolescent; Adult; Blood Transfusion; Bone Density; Bone Density Conservation Agents; Calcium; Dipho | 2009 |